Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology - Wikidata - awgldk - TriplyDB

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

http://www.wikidata.org/entity/Q22241656

about

Lyme disease: review Lyme Disease Chronic Lyme disease Treatment for the neurological complications of Lyme disease The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines Methodological quality of guidelines for management of Lyme neuroborreliosis.A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.[Challenge of neuroborreliosis].Diagnostic challenges of early Lyme disease: lessons from a community case series Proof that chronic lyme disease exists.Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy.Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy).Chronic Lyme disease: the controversies and the science.ALS untangled No. 17: "when ALS is lyme".Lyme Neuroborreliosis: Preliminary Results from an Urban Referral Center Employing Strict CDC Criteria for Case Selection Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study.Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review.A case of chronic progressive lyme encephalitis as a manifestation of late lyme neuroborreliosis.Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA.Chronic Lyme disease: misconceptions and challenges for patient management Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review.Neuroborreliosis: the Guillain-Barré mimicker Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome Targeting CXCL13 During Neuroinflammation Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.Management of Lyme disease.Management of neuroborreliosis in European adult patients.Immunogenetic Markers Definition in Latvian Patients with Lyme Borreliosis and Lyme Neuroborreliosis.Lyme neuroborreliosis in children.Treatment of infection caused by Borrelia burgdorferi sensu lato.Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy.Incidence and Patterns of Extended-Course Antibiotic Therapy in Patients Evaluated for Lyme Disease.Nervous system Lyme disease, chronic Lyme disease, and none of the above.The burden and epidemiology of community-acquired central nervous system infections: a multinational study.Antibiotics for the neurological complications of Lyme disease.Cerebrovascular Manifestations of Lyme Neuroborreliosis-A Systematic Review of Published Cases.Treatment-Related Complications in Children Hospitalized With Disseminated Lyme Disease.[Neuroborreliosis - Diagnostics, treatment and course].Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes.

P2860

Q22241162-DDC81FBF-6F0D-449E-BE33-46BC8599BBA0 Q22250895-803DBE53-68A9-405C-BF70-8C7F13D9B42D Q22252195-6E829FCB-8DE6-47CF-AC1A-C08E2D42D208 Q24243765-F811244C-DDA8-4B52-A30C-5C73F0A20FAE Q24288916-951B13A6-9301-4ECC-BC0E-BBBD62184663 Q26775435-4BC8E120-1A34-4873-B1A8-304FCD8B80B8 Q30240203-3DA0161F-18CB-4189-9853-68CD94188D3B Q30241225-DA87E48A-0AA0-4A47-85B9-907A98E18872 Q33457704-089EAB7A-5DB3-4031-8585-27EA7BD27D52 Q33876091-EC0EAFD7-E996-420C-97F4-B43436AB7A45 Q33898972-C1828DD2-6944-46B6-AB2C-F1EE32D9CBCA Q33989418-C038FC2A-1FA2-4EE1-99F5-9A30ACA26AF3 Q34205531-78BF6C1D-BDB2-43D7-9337-5889D9E4C8AA Q34292843-DC81D977-12F8-409F-B14F-A71143B57C57 Q34340079-64735EBC-01C8-4A9C-8236-C454E99DA3FE Q34372745-9211C33C-0C78-41AE-8130-2A753D77D2F0 Q34391745-00A83EA2-39C5-4648-8425-451180AF3C8A Q34760336-59E1AA6C-9AB5-4CF6-A854-79D959C68D55 Q35207029-774C808E-4961-4101-B46B-FC784E51271E Q35633278-1CF9A92E-57C9-4F8B-8683-ABCB57CD313E Q35658597-E0CB5E79-238F-4BC1-9AA7-9A6EB963F94C Q35808450-40CADF6B-C118-45F2-8F46-F15F1648DF93 Q36149067-AE756F25-88AB-45BB-9427-2F1BC43B089F Q36328746-E1203BAC-EDE5-44A5-BF35-49FF40B1D468 Q36551188-279F0EE2-FF6C-4261-ABBB-AE8E4ED68C65 Q36587202-CA537017-D80E-4BD6-828D-FEFE6DB5A96C Q37124900-F36EB995-C27A-4B02-82D4-44DC7254B5EC Q37148487-08D218E6-B072-4F4B-A80F-4E0B3108FBA0 Q37546409-FAC8647D-FFB8-4783-8E1D-C3BC538A2AB4 Q37727179-9B00627D-5CFB-4FF3-9167-AC5D32775031 Q37845853-FCA48D93-A2BE-4180-8F17-93243AB6BAAA Q37869389-7717FF5F-FC2B-4259-82BB-941B051482FC Q38557153-F3AD4CDB-50FE-45BE-9144-E1896707D6C4 Q38588148-0ABA1F20-C7C8-4D52-929F-B3EA1CE66643 Q38843270-F6B1C709-371D-48FB-A73D-836789F78D98 Q39032987-74AC87AA-95DB-46B8-A1EA-491B09DD4223 Q39284826-E22A498A-AED9-448F-83C2-0C14D50C9E5F Q40048513-E08E9E91-C54C-4045-82F8-184C72A29EED Q40340882-A71EE1E8-EF52-4113-A0F6-CCC5CDADBBC6 Q40593725-D9C675D1-D732-40A9-A371-31CE9D3FA718

P2860

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

http://www.wikidata.org/entity/Q22241656

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Practice Parameter: Treatment ...... American Academy of Neurology

@ast

Practice Parameter: Treatment ...... American Academy of Neurology

@en

Practice Parameter: Treatment ...... American Academy of Neurology

@en-gb

Practice Parameter: Treatment ...... American Academy of Neurology

@nl

type

label

Practice Parameter: Treatment ...... American Academy of Neurology

@ast

Practice Parameter: Treatment ...... American Academy of Neurology

@en

Practice Parameter: Treatment ...... American Academy of Neurology

@en-gb

Practice Parameter: Treatment ...... American Academy of Neurology

@nl

altLabel

Practice parameter: treatment ...... American Academy of Neurology

@en

prefLabel

Practice Parameter: Treatment ...... American Academy of Neurology

@ast

Practice Parameter: Treatment ...... American Academy of Neurology

@en

Practice Parameter: Treatment ...... American Academy of Neurology

@en-gb

Practice Parameter: Treatment ...... American Academy of Neurology

@nl

P1433

Q22241656-9E762854-73E3-43C5-9ECD-F6587D9B27F0

P1476

Q22241656-0A74C671-CC84-4CAE-B00C-9CEF29BD21C7

P2093

Q22241656-1F6158AB-80B7-4173-9A87-9EF22FFF9DE9

Q22241656-28A120BD-4239-4E73-9CD9-9A42B3897D09

Q22241656-363DB450-2063-4E01-8FEE-2E8DA129203B

Q22241656-64717424-34E8-4D7A-B4FA-00ED0E5870C6

Q22241656-7A37A026-A045-4041-B41D-A9454D0A82B2

Q22241656-8B7662F1-F69A-44AD-AA7F-F80778A971F1

Q22241656-EEC65395-0910-4B26-9E83-393C2ADF01D6

Q22241656-F9A26CE6-063F-4CEB-96D1-4A9B478F69F0

Q22241656-FFB14B03-5DC1-43E9-AF22-AA0B19FC9639

P304

Q22241656-4A807D07-9DF9-4F64-A433-0F6B9864B9D4

P31

Q22241656-B960358D-C352-4A6A-8D3D-5CA70047A9F5

P3181

Q22241656-D59464A9-386E-4AFF-8C3E-9E3AC775243D

P356

Q22241656-B6F033C6-2B53-4E42-B0D1-F9AAC7A0CBE5

P407

Q22241656-19FBB8A3-72B8-4784-9677-51DF81F182AA

P433

Q22241656-3435D7E6-47F9-4617-A88E-CB9B055EB8C8

P478

Q22241656-CB6AA10A-5FC2-46B3-915A-16E59503652D

P50

Q22241656-9B986452-5A6E-41DC-B3E2-03F64C5BFA89

P577

Q22241656-74AD154D-8C4D-4443-84E2-04D7687B056D

P5875

Q22241656-0E2C4636-B325-44AB-A705-500B3F89944E

P698

Q22241656-582C7085-B402-4209-B0CB-21DFB9C9378D

P921

Q22241656-50E04C84-6E6D-4FE8-B3BB-63B970E06B2D

P3181

P356

01.WNL.0000265517.66976.28

P1433

P1476

Practice parameter: treatment ...... American Academy of Neurology

@en

P2093

A L Belman

http://www.w3.org/2001/XMLSchema#string

C T Bever

http://www.w3.org/2001/XMLSchema#string

E D Shapiro

http://www.w3.org/2001/XMLSchema#string

E Logigian

http://www.w3.org/2001/XMLSchema#string

G Gronseth

http://www.w3.org/2001/XMLSchema#string

G P Wormser

http://www.w3.org/2001/XMLSchema#string

L Dotevall

http://www.w3.org/2001/XMLSchema#string

L Krupp

http://www.w3.org/2001/XMLSchema#string

Quality Standards Subcommittee of the American Academy of Neurology

http://www.w3.org/2001/XMLSchema#string

P304

91-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3269389

http://www.w3.org/2001/XMLSchema#string

P356

10.1212/01.WNL.0000265517.66976.28

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

John J Halperin

P577

2007-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6311205

http://www.w3.org/2001/XMLSchema#string

P698

17522387

http://www.w3.org/2001/XMLSchema#string

P921